The major share of the market in current years will belong to North America. The main reasons for this are that North America holds most of the key players in the world and is a hub for technological advancements in the world of medicine.
Isle of Man, Nov. 11, 2022 (GLOBE NEWSWIRE) — Douglas Insights, the world’s first market comparison engine, has also added DNA repair drugs market report to its database. Market analysts, businesses, researchers, and all other relevant personnel can now use this database information for particular purposes. In addition to identifying market trends, the Douglas Insight Comparison Engine will assist users in identifying market drivers, restraining factors, opportunities, and future forecasts across all markets. The comparison engine is also well-organized, allowing users to sort relevant information by price, publication date, rating, and a general table of contents.
DNA repair drugs enable the structural repair of DNA tissue in patients, thereby optimizing the replication mechanism and preventing the progression of DNA-related genetic disorders. The drugs aim to restore DNA function by repairing any structural or molecular damage that can impair the body’s coding sequence and lead to a variety of harmful health conditions. Cancer is a condition that will benefit greatly from DNA repair drugs.
Compare the report and make your decision – https://douglasinsights.com/dna-repair-drugs-market
Market Drivers
Consequently, one of the major drivers in the DNA repair drugs market is the prevalence of cancer, which is one of the leading causes of death worldwide. Because a disruption in DNA sequence causes cancer cell proliferation, DNA repair drugs will assist in correcting the sequence and allow for the appropriate treatment of cancer. The demand for newer drug technology is an additional market driver. DNA repair drugs are part of the new generation of drugs across the globe, and as the market grows, the need for these drugs will also grow.
In addition, governments across the globe are working to raise awareness of cancer and available treatment options. The rise in cancer awareness and relevant treatment methods will also create opportunities and expand the market.
The majority of the market in recent years has been in North America. The main reasons for this are that North America holds most of the key players in the world and is a hub for technological advancements in the world of medicine. In addition, Asia-Pacific will hold significant market shares for DNA repair drugs. This is due to the region’s awareness campaigns, growing awareness, and the region’s high cancer prevalence. Because cancer is so prevalent in Asia-Pacific, DNA repair drugs are likely to also experience growth in these regions.
There are several well-known key players on the DNA repair drug market. Some examples are AstraZeneca, Pfizer, Artios Pharma, Johnson & Johnson Services, GlaxoSmithKline, Clovis Oncology, and Bristol-Myers Squibb Company. These key players have saturated the market, and their new development strategies are driving it significantly. Their growth and development strategies will also pave the way for newer developments in the region.
Clovis Oncology and Bristol-Myers Squibb have joined forces to conduct clinical trials and advance the development of DNA repair drugs. In these clinical trials, the drugs in question are Rucaparib and Nivolumab. The drugs in question are primarily used to treat breast and ovarian cancers in women, but the database will soon be able to include information on additional types of cancer.
Key players
The major players operating in the DNA Repair Drugs market are AstraZeneca, Pfizer, Artios Pharma, Johnson & Johnson Services, GlaxoSmithKline, Clovis Oncology, and Bristol-Myers Squibb Company.
Set a budget for a custom project and see offers from publishers all over the world- https://douglasinsights.com/projects
DNA Repair Drugs Market Report Coverage
| Report Attributes | Details |
| Market Size in 2021 | $XXBN |
| Market Size Projection in 2028 | $XX BN |
| CAGR (2018-2025) | XX % |
| Largest Market | North America |
| Growth Drivers | The prevalence of cancer, The need for newer drug technology, Rise in awareness about cancer, and the relevant treatment methods. |
| Segmentation | By Technology Type (Poly(ADP-Ribose) Polymerase Inhibitors, Structure and Function of PARP Inhibitors, Use of PARP Inhibitors in Treatment, FDA-approved PARP Inhibitors for Use in Cancer Treatment, PARP Inhibitors in Clinical Trials) By Application (Ovarian Cancer, Epidemiology of Ovarian Cancer, Risk Factors for Ovarian Cancer, Breast Cancer, Risk Factors for Breast Cancer, Signs and Symptoms, Treatment, Challenges, Global Impact) |
| Regional Analysis | North America (US, Canada), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Europe (U.K, Germany, Italy, France, Spain, Russia and Rest of Europe), APAC (China, Japan, India, South Korea, Australia, ASEAN and Rest of Asia Pacific), ME (GCC Countries, Israel, and Rest of Middle East) & Africa (South Africa, North Africa and Central Africa) |
| Key Companies Covered | AstraZeneca, Pfizer, Artios Pharma, Johnson & Johnson Services, GlaxoSmithKline, Clovis Oncology, and Bristol-Myers Squibb Company |
Segmentations
By Technology Type
- Poly(ADP-Ribose) Polymerase Inhibitors
- Structure and Function of PARP Inhibitors
- Use of PARP Inhibitors in Treatment
- FDA-approved PARP Inhibitors for Use in Cancer Treatment
- PARP Inhibitors in Clinical Trials
By Application
- Ovarian Cancer
- Epidemiology of Ovarian Cancer
- Risk Factors for Ovarian Cancer
- Breast Cancer
- Risk Factors for Breast Cancer
- Signs and Symptoms
- Treatment
- Challenges
- Global Impact
Key questions answered in this report
- COVID 19 impact analysis on global DNA Repair Drugs industry.
- What are the current market trends and dynamics in the DNA Repair Drugs market and valuable opportunities for emerging players?
- What is driving DNA Repair Drugs market?
- What are the key challenges to market growth?
- Which segment accounts for the fastest CAGR during the forecast period?
- Which product type segment holds a larger market share and why?
- Are low and middle-income economies investing in the DNA Repair Drugs market?
- Key growth pockets based on regions, types, applications, and end-users
- What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa
Unique data points of this report
- Statistics on DNA Repair Drugs and spending worldwide
- Recent trends across different regions in terms of adoption of DNA Repair Drugs across industries
- Notable developments going on in the industry
- Attractive investment proposition for segments as well as geography
- Comparative scenario for all the segments for years 2018 (actual) and 2028 (forecast)
Table of Content:
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Market Estimates
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
DNA Damage
Sources of DNA Damage
DNA Repair Mechanism
Base Excision Repair and Nucleotide Excision Repair
Repair of Double-Strand Breaks
Nucleotide Excision Repair
Mismatch Repair
Homologous Recombination (HR)
Non-Homologous End Joining (NHEJ)
Alternative End Joining
Targets for Cancer Therapy
DNA Damage Response for Cancer Chemotherapy
Targeting PARP-1
Targeting APE 1
Targeting XRCC 1
Targeting DNA-PKcs
Targeting Ligases
Targeting PI-3 kinase
Chapter 4 Market Breakdown by Technology Type
Poly(ADP-Ribose) Polymerase Inhibitors
Structure and Function of PARP Inhibitors
Use of PARP Inhibitors in Treatment
FDA-approved PARP Inhibitors for Use in Cancer Treatment
PARP Inhibitors in Clinical Trials
Chapter 5 Market Breakdown by Application
Ovarian Cancer
Epidemiology of Ovarian Cancer
Risk Factors for Ovarian Cancer
Breast Cancer
Risk Factors for Breast Cancer
Signs and Symptoms
Treatment
Challenges
Global Impact
Chapter 6 Market Breakdown by Region
Market Overview and Discussion
Rise of DNA Repair Cases by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 R&D in the Pharmaceutical Industry
Healthcare Expenditures
Continued Emphasis on R&D Activities
Trends in the Pharmaceutical Industry
Factors Influencing Spending for R&D
Trends in R&D Spending and New Drug Development
R&D Spending
New Drug Development
Approvals of New Drugs
Trends in Recent Drug Spending by Therapeutic Class
Types of New Drug Development
Factors Influencing R&D Spending
Projected Revenues
Revenues as Funding for R&D
New Drug Costs in R&D
Chapter 8 DNA Repair Inhibitors on SARS-CoV-2
Biological Structure of SARS-CoV-2
Viral Infection Induces DNA Damage
Federal Funding for the Development of COVID-19 Vaccines
…………….. ToC continued
Compare the report and make your decision –https://douglasinsights.com/dna-repair-drugs-market
Inquire Before Buying This Research Report:https://douglasinsights.com/static/contact-us
Follow Douglas Insights For More Industry Updates- @ LinkedIn & Twitter
About Douglas Insights-
Douglas Insights UK Limited is the first company to provide a comparison of market research reports by Table of content, price, ratings and number of pages. We understand the value of time. Productivity and efficiency are possible when you take prompt and assured decisions. With our advanced algorithm, filters, and comparison engine, you can compare your preferred reports simultaneously based on publisher rating, published date, price, and list of tables. Our data portal enables you to find and review reports from several publishers. You can evaluate numerous reports on the same screen and select the sample for your best match.
Similar Market Research Report Comparisons:
DNA Vaccines Market: The study’s scope includes DNA vaccine products that are already commercialized or likely to be in the next five years.
cDNA And oDNA Microchips Market: The global cDNA and oDNA microchips market is growing effectively, was valued at US$ 458.2 Mn in 2017 and is expected to reach US$ 1,050.3 Mn by 2026.
DNA Sequencing Market: The report covers sequencing technologies, industries, applications, patents, initiatives, and companies. The sequencing services and products markets are given for the years 2020, 2021 and 2026.
DNA-based Skin Care Products Market: Global DNA-based Skin Care Products Market is valued at approximately USD 5.90 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.6% over the forecast period 2021-2027.
CONTACT: Office- Bridge House, W Baldwin Rd, Isle of Man IM4 5HA, Isle of Man Email- [email protected] Telephone - +44 7624 248772 Web- douglasinsights.com/
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Mango Bunch takes no editorial responsibility for the same.